PSTV Projected Dividend Yield
Com Par $0.001/Plus Therapeutics Inc ( NASDAQ : PSTV )Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. Co. is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. Co. combines image-guided local beta radiation and targeted drug delivery approaches. Co. is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium (186Re) obisbemeda, is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC). 20 YEAR PERFORMANCE RESULTS |
PSTV Dividend History Detail PSTV Dividend News PSTV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |